Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors

Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors

US Patent 6420341 · Granted Jul 16, 2002

Estimated economic value: $1,715,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2023
Anti-CD38 antibodies and formulations2023
5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2021
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMT2020
Aryl ureas with angiogenisis inhibiting activity2020
5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS2020
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2019
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2018
Aryl ureas as kinase inhibitors2015
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors2014
Diaryl ureas for diseases mediated by PDGFR2014
Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevent2014